Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemi...
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John’s wort: an [11 C]-harmine PET study
About this item
Full title
Author / Creator
Publisher
Ottawa, ON: Canadian Medical Association
Journal title
Language
English
Formats
Publication information
Publisher
Ottawa, ON: Canadian Medical Association
Subjects
More information
Scope and Contents
Contents
Background Monoamine oxidase A (MAO-A) inhibitor antidepressants raise levels of multiple monoamines, whereas the selective serotonin reuptake inhibitors (SSRIs) only raise extracellular serotonin. Despite this advantage of MAO-A inhibitors, there is much less frequent development of MAO inhibitors compared with SSRIs. We sought to measure brain MA...
Alternative Titles
Full title
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John’s wort: an [11 C]-harmine PET study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3201991
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3201991
Other Identifiers
ISSN
1180-4882
E-ISSN
1488-2434
DOI
10.1503/jpn.100117
